|
|
||||||||
1Department of Pediatrics, University of Groningen, Beatrix Children's Hospital and Research School Guide, 9713 GZ Groningen, The Netherlands; 2Department of Pediatrics, Vanderbilt University Medical Center, Nashville, Tennessee 37232-2495; 3Cellular Biochemistry, Hannah Research Institute, KA6 5ML Scotland, United Kingdom; and 4Endocrinology Department, Institut Cochin, Institut National de la Santé et de la Recherche Médicale Unité 567, 75014 Paris, France
Submitted 9 September 2003 ; accepted in final form 27 January 2004
Carnitine palmitoyltransferase I (CPT I) catalyzes the conversion of acyl-CoA to acylcarnitine at the outer mitochondrial membrane and is a key enzyme in the control of long-chain fatty acid (LC-FA) oxidation. Because myocardial LC-FA oxidation increases dramatically after birth, we determined the extent to which CPT I expression contributes to these changes in the perinatal lamb. We measured the steady-state level of transcripts of the CPT1A and CPT1B genes, which encode the liver (L-CPT I) and muscle CPT I (M-CPT I) isoforms, respectively, as well as the amount of these proteins, their total activity, and the amount of carnitine in left ventricular tissue from fetal and newborn lambs. We compared these data with previously obtained myocardial FA oxidation rates in vivo in the same model. The results showed that CPT1B was already expressed before birth and that total CPT I expression transiently increased after birth. The protein level of M-CPT I was high throughout development, whereas that of L-CPT I was only transiently upregulated in the first week after birth. The total CPT I activity in vitro also increased after birth. However, the increase in myocardial FA oxidation measured in vivo (112-fold) by far exceeded the increase in gene expression (2.2-fold), protein amount (1.1-fold), and enzyme activity (1.2-fold) in vitro. In conclusion, these results stress the importance of substrate supply per se in the postnatal increase in myocardial FA oxidation. M-CPT I is expressed throughout perinatal development, making it a primary target for metabolic modulation of myocardial FA oxidation.
cardiac muscle; gene expression; free fatty acid; cardiac metabolism
This article has been cited by other articles:
![]() |
A. K. Olson, O. M. Hyyti, G. A. Cohen, X.-H. Ning, M. Sadilek, N. Isern, and M. A. Portman Superior cardiac function via anaplerotic pyruvate in the immature swine heart after cardiopulmonary bypass and reperfusion Am J Physiol Heart Circ Physiol, December 1, 2008; 295(6): H2315 - H2320. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. D. McClure, M. E. Young, H. Taegtmeyer, X.-H. Ning, N. E. Buroker, J. Lopez-Guisa, and M. A. Portman Thyroid hormone interacts with PPAR{alpha} and PGC-1 during mitochondrial maturation in sheep heart Am J Physiol Heart Circ Physiol, November 1, 2005; 289(5): H2258 - H2264. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. N. Lavrentyev, D. He, and G. A. Cook Expression of genes participating in regulation of fatty acid and glucose utilization and energy metabolism in developing rat hearts Am J Physiol Heart Circ Physiol, November 1, 2004; 287(5): H2035 - H2042. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |